Suppr超能文献

肝脏中甘露糖和半乳糖受体对组织型纤溶酶原激活物的清除作用。

Clearance of tissue plasminogen activator by mannose and galactose receptors in the liver.

作者信息

Smedsrød B, Einarsson M

机构信息

Institute of Medical Biology, University of Tromsø, Norway.

出版信息

Thromb Haemost. 1990 Feb 19;63(1):60-6.

PMID:2160132
Abstract

The mechanism of uptake of radio-iodinated tissue plasminogen activator (125I-t-PA) was studied in rats. When trace amounts of 125I-t-PA were injected alone, the clearance followed a biphasic pattern in which 65% and 35% were cleared with alpha- and beta-kinetics (t1/2 (alpha) = 0.6 min, and t1/2 (beta) = 6.4 min), respectively. Co-injection with excess unlabelled t-PA or mannan changed the uptake kinetics to the monophasic beta-elimination pattern. Mannosylated albumin and ovalbumin, both of which bind to the hepatic mannose receptor, reduced the proportion of t-PA cleared with t1/2 (alpha) to 48% and 21%, respectively. A corresponding increase in the beta-elimination of t-PA was observed. The t1/2 (alpha) and t1/2 (beta) were unchanged. Studies on the clearance of 125I-ovalbumin also showed a biphasic elimination with an initial rapid phase, t1/2 (alpha), accounting for only 39% of the clearance of ovalbumin, as compared to 65% in the case of t-PA. Macromolecules with affinity for the galactose-receptor only, such as asialofetuin, or galactosylated albumin, did not significantly affect the clearance kinetics at the concentrations used. Asialoorosomucoid, which also carries galactosyl residues in the terminal position, reduced somewhat (from 65% to 48%) the proportion cleared with alpha-kinetics. Very high concentrations of galactose and N-acetyl-galactosamine, which are also known to compete for binding to the galactose receptor, lowered the proportion of t-PA cleared in the late beta-phase (reduced from 35% to 26% with galactose and to 19% with N-acetyl-galactosamine).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在大鼠中研究了放射性碘化组织型纤溶酶原激活剂(125I-t-PA)的摄取机制。当单独注射微量的125I-t-PA时,清除呈现双相模式,其中65%和35%分别以α和β动力学清除(t1/2(α)=0.6分钟,t1/2(β)=6.4分钟)。与过量未标记的t-PA或甘露聚糖共同注射会将摄取动力学改变为单相β消除模式。甘露糖基化白蛋白和卵清蛋白都与肝甘露糖受体结合,分别将以t1/2(α)清除的t-PA比例降低到48%和21%。观察到t-PA的β消除相应增加。t1/2(α)和t1/2(β)未改变。对125I-卵清蛋白清除的研究也显示出双相消除,初始快速相t1/2(α)仅占卵清蛋白清除的39%,而t-PA的这一比例为65%。仅对半乳糖受体有亲和力的大分子,如去唾液酸胎球蛋白或半乳糖基化白蛋白,在所使用的浓度下对清除动力学没有显著影响。末端也带有半乳糖基残基的去唾液酸血清类黏蛋白稍微降低了(从65%降至48%)以α动力学清除的比例。已知也竞争与半乳糖受体结合的非常高浓度的半乳糖和N-乙酰半乳糖胺降低了t-PA在后期β相清除的比例(半乳糖使其从35%降至26%,N-乙酰半乳糖胺使其降至19%)。(摘要截断于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验